BioSpace News Archive

Modular Medical, Inc. today announced the appointment of medical device industry leader Duane DeSisto to its board of directors.

Theradaptive, a biopharmaceutical firm pioneering advancements in targeted regenerative therapeutics, has been awarded the Manufacturing Assistance Program grant by the Maryland Stem Cell Research Fund.

VBI Vaccines Inc. today announced the pricing of its previously announced underwritten public offering of 10,909,091 common shares.

Summer is the perfect time for picnics and barbecues. During these outdoor gatherings, it’s important to keep food safety in mind.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, has been granted full Marketing Authorization (MA) by the European Commission in the European Union (EU) for Nuvaxovid™ (NVX-CoV2373).

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the Company’s results for the quarter ended March 31, 2023.

IPS HEART today announced that the U.S. Food and Drug Administration (FDA) awarded a third Rare Pediatric Drug Designation (RPDD) for its product candidate, ISX9-CPC, for treatment of cardiomyopathy associated with Danon disease.

Sensus Healthcare, Inc. announces a partnership with MIS Healthcare to distribute Sensus’ superficial radiation therapy products in the United Kingdom and Ireland.

Allarity Therapeutics, Inc. announced the pricing of its “reasonable best efforts” public offering of 2,444,445 shares of common stock and common warrants to purchase up to 2,444,445 shares of common stock at an effective combined price of $4.50 per share and common warrant for aggregate gross proceeds of approximately $11 million, before deducting placement agent fees and other offering expenses.

Sapio Sciences, the science-aware™ lab informatics platform, announced that since recently launching in the EMEA geography, NatureMetrics, the nature intelligence technology company, has adopted Sapio’s platform to power its use of eDNA surveys and sequencing to identify and explore biodiversity.